• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲银屑病中与患者相关的需求和治疗目标

Patient-relevant needs and treatment goals in nail psoriasis.

作者信息

Blome C, Costanzo A, Dauden E, Ferrandiz C, Girolomoni G, Gniadecki R, Iversen L, Menter A, Michaelis-Wittern K, Morita A, Nakagawa H, Reich K, Augustin M

机构信息

Institute for Health Services Research in Dermatology and Nursing (IVDP), German Center of Health Services Research in Dermatology (CVderm), University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.

Dermatology Unit, NESMOS Department, Department of Dermatology, University of Rome 'Tor Vergata', Rome, Italy.

出版信息

Qual Life Res. 2016 May;25(5):1179-88. doi: 10.1007/s11136-015-1136-y. Epub 2015 Oct 3.

DOI:10.1007/s11136-015-1136-y
PMID:26433952
Abstract

PURPOSE

Patient-centered health care implies that medical decisions are made jointly by physician and patient, based on patient needs. Aims were to (a) identify treatment goals for a new questionnaire on patient needs and benefits in nail psoriasis treatment; (b) analyze the importance of treatment goals in patients with nail psoriasis in general and in defined subgroups; and (c) determine the association between overall treatment goal importance and quality of life.

METHODS

The study comprised the following steps: qualitative survey on needs and burdens in 120 patients; development of items by an interdisciplinary expert group; item testing in 55 patients in four countries; revision of the questionnaire and assessment in 203 patients in six countries (Germany, Denmark, Italy, Spain, USA, Japan). The percentage of patients rating the goals as 'quite/very important' was compared between various patient subgroups.

RESULTS

Based on 692 free-text statements, 26 items were developed which were reduced to 24 items after pilot testing. Each of these treatment goals applied to the majority of patients in the multi-center study. Goal importance increased with severity of nail psoriasis, but not with age or disease duration. Manual dexterity and social interaction were of particular importance. Goal importance and quality of life were associated, but not redundant (r = 0.612, p < 0.001).

CONCLUSIONS

Patients with nail psoriasis have manifold and specific treatment goals. Goal importance is a construct different from disease-specific quality of life and should be assessed separately. The new questionnaire can support goal setting in clinical practice.

摘要

目的

以患者为中心的医疗保健意味着医疗决策由医生和患者根据患者需求共同做出。本研究旨在:(a)确定一份关于甲银屑病治疗中患者需求和益处的新问卷的治疗目标;(b)分析治疗目标在一般甲银屑病患者及特定亚组患者中的重要性;(c)确定总体治疗目标重要性与生活质量之间的关联。

方法

本研究包括以下步骤:对120名患者的需求和负担进行定性调查;由跨学科专家组制定条目;在四个国家的55名患者中进行条目测试;对问卷进行修订并在六个国家(德国、丹麦、意大利、西班牙、美国、日本)的203名患者中进行评估。比较不同患者亚组中认为目标“相当/非常重要”的患者百分比。

结果

基于692条自由文本陈述,制定了26个条目,经过预试验后减少至24个条目。这些治疗目标中的每一个都适用于多中心研究中的大多数患者。目标重要性随甲银屑病严重程度增加而增加,但不随年龄或病程增加。手部灵活性和社交互动尤为重要。目标重要性与生活质量相关,但并非冗余相关(r = 0.612,p < 0.001)。

结论

甲银屑病患者有多种特定的治疗目标。目标重要性是一个不同于疾病特异性生活质量的概念,应单独评估。新问卷可支持临床实践中的目标设定。

相似文献

1
Patient-relevant needs and treatment goals in nail psoriasis.甲银屑病中与患者相关的需求和治疗目标
Qual Life Res. 2016 May;25(5):1179-88. doi: 10.1007/s11136-015-1136-y. Epub 2015 Oct 3.
2
Assessing the Importance of Treatment Goals in Patients with Psoriasis: Analytic Hierarchy Process vs. Likert Scales.评估银屑病患者治疗目标的重要性:层次分析法与李克特量表。
Patient. 2018 Aug;11(4):425-437. doi: 10.1007/s40271-018-0300-1.
3
Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes.银屑病和银屑病关节炎的甲病评估(NAPPA):一种评估甲银屑病结局的工具的制定和验证。
Br J Dermatol. 2014 Mar;170(3):591-8. doi: 10.1111/bjd.12664.
4
Patient-relevant treatment goals in psoriasis.银屑病中与患者相关的治疗目标。
Arch Dermatol Res. 2016 Mar;308(2):69-78. doi: 10.1007/s00403-015-1613-8. Epub 2015 Dec 19.
5
Treatment of nail psoriasis: best practice recommendations from the Medical Board of the National Psoriasis Foundation.甲银屑病治疗:全国银屑病基金会医学委员会的最佳实践推荐。
JAMA Dermatol. 2015 Jan;151(1):87-94. doi: 10.1001/jamadermatol.2014.2983.
6
How to weight patient-relevant treatment goals for assessing treatment benefit in psoriasis: preference elicitation methods vs. rating scales.如何权衡与患者相关的治疗目标,以评估银屑病的治疗获益:偏好 elicitation 方法与评分量表。
Arch Dermatol Res. 2018 Sep;310(7):567-577. doi: 10.1007/s00403-018-1846-4. Epub 2018 Jun 23.
7
Treatment goals in psoriasis routine care.银屑病常规护理中的治疗目标。
Arch Dermatol Res. 2015 Jul;307(5):445-9. doi: 10.1007/s00403-014-1534-y. Epub 2014 Dec 31.
8
Efficacy of ustekinumab in nail psoriasis and improvement in nail-associated quality of life in a population treated with ustekinumab for cutaneous psoriasis: an open prospective unblinded study.乌司奴单抗治疗皮肤银屑病人群中指甲银屑病的疗效及对指甲相关生活质量的改善:一项开放性前瞻性非盲研究。
Dermatology. 2011;223(4):325-9. doi: 10.1159/000334482. Epub 2011 Nov 30.
9
Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.英夫利昔单抗治疗银屑病甲的疗效和安全性评估:一项非盲、非随机、开放标签研究。
Br J Dermatol. 2008 Aug;159(2):453-6. doi: 10.1111/j.1365-2133.2008.08686.x. Epub 2008 Jun 28.
10
Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.系统性治疗药物对银屑病指甲的疗效:一项比较研究。
J Drugs Dermatol. 2013 Sep;12(9):1039-43.

引用本文的文献

1
Development of a modular patient-reported outcome and experience measure on patient needs and benefits in CLL (PBI-CLL).关于慢性淋巴细胞白血病患者需求与获益的模块化患者报告结局与体验测量工具(PBI-CLL)的开发。
J Patient Rep Outcomes. 2025 Apr 29;9(1):45. doi: 10.1186/s41687-025-00882-5.
2
Development of a Specific Variant of Patient Benefit Index (PBI) Assessing Patient Needs, Goals and Benefits in Rosacea Treatment.开发一种特定变体的患者获益指数(PBI),用于评估酒渣鼻治疗中的患者需求、目标和获益。
Patient Prefer Adherence. 2023 Jun 1;17:1335-1345. doi: 10.2147/PPA.S378724. eCollection 2023.
3
Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study).

本文引用的文献

1
Evaluation of patient-relevant outcomes of lymphedema and lipedema treatment: development and validation of a new benefit tool.评估淋巴水肿和脂肪水肿治疗的患者相关结局:一种新获益工具的开发和验证。
Eur J Vasc Endovasc Surg. 2014 Jan;47(1):100-7. doi: 10.1016/j.ejvs.2013.10.009. Epub 2013 Oct 22.
2
Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes.银屑病和银屑病关节炎的甲病评估(NAPPA):一种评估甲银屑病结局的工具的制定和验证。
Br J Dermatol. 2014 Mar;170(3):591-8. doi: 10.1111/bjd.12664.
3
Nail psoriasis - a treatment challenge.
基于真实世界数据使用特诺雅治疗患者的报告健康状况:一项多国、四期、单队列前瞻性观察研究(POSITIVE 研究)方案。
BMJ Open. 2023 Feb 15;13(2):e060536. doi: 10.1136/bmjopen-2021-060536.
4
Assessment of body perception disturbances in complex regional pain syndrome: A systematic review using the COSMIN guideline.评估复杂性区域疼痛综合征中的躯体知觉障碍:使用 COSMIN 指南的系统评价。
Eur J Pain. 2022 Nov;26(10):2060-2073. doi: 10.1002/ejp.2032. Epub 2022 Sep 19.
5
Nail Psoriasis and Quality-of-Life Measurement in Clinical Trials: Call for the Use of Nail-Specific Instruments.指甲银屑病与临床试验中的生活质量评估:呼吁使用指甲专用工具。
Am J Clin Dermatol. 2021 Nov;22(6):747-755. doi: 10.1007/s40257-021-00622-7. Epub 2021 Aug 12.
6
Unmet Personal Patient Needs in Psoriasis Patients with Low Disease Activity on Adalimumab, Etanercept or Ustekinumab.使用阿达木单抗、依那西普或乌司奴单抗治疗后疾病活动度低的银屑病患者未满足的个人患者需求
Drugs Real World Outcomes. 2021 Jun;8(2):163-172. doi: 10.1007/s40801-021-00227-w. Epub 2021 Mar 28.
7
Efficacy of Biologics Targeting Tumour Necrosis Factor-alpha, Interleukin-17 -12/23, -23 and Small Molecules Targeting JAK and PDE4 in the Treatment of Nail Psoriasis: A Network Meta-analysis.靶向肿瘤坏死因子-α、白细胞介素-17、-12/23、-23的生物制剂以及靶向JAK和PDE4的小分子药物治疗甲银屑病的疗效:一项网状Meta分析
Acta Derm Venereol. 2020 Nov 12;100(18):adv00318. doi: 10.2340/00015555-3640.
甲银屑病——一种治疗挑战。
J Dtsch Dermatol Ges. 2013 Mar;11(3):203-19; quiz 220. doi: 10.1111/ddg.12054.
4
Nail psoriasis: a review.甲银屑病:综述。
Am J Clin Dermatol. 2012 Dec 1;13(6):375-88. doi: 10.2165/11597000-000000000-00000.
5
Validation of the patient benefit index for the assessment of patient-relevant benefit in the treatment of psoriasis.验证患者获益指数在评估银屑病治疗中患者相关获益的应用。
Arch Dermatol Res. 2012 Aug;304(6):433-41. doi: 10.1007/s00403-012-1256-y. Epub 2012 Jun 22.
6
Gender differences in self-conscious emotional experience: a meta-analysis.性别差异在自我意识情绪体验中的作用:一项荟萃分析。
Psychol Bull. 2012 Sep;138(5):947-81. doi: 10.1037/a0027930. Epub 2012 Apr 2.
7
Shared decision making--pinnacle of patient-centered care.共同决策——以患者为中心的医疗的巅峰。
N Engl J Med. 2012 Mar 1;366(9):780-1. doi: 10.1056/NEJMp1109283.
8
Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations.在临床实践中实施患者报告结局评估:选项和考虑因素的综述。
Qual Life Res. 2012 Oct;21(8):1305-14. doi: 10.1007/s11136-011-0054-x. Epub 2011 Nov 3.
9
Methods for the comparative evaluation of pharmaceuticals.药物的比较评估方法。
GMS Health Technol Assess. 2005 Nov 15;1:Doc09.
10
The burden of nail psoriasis: an introduction.指甲银屑病的负担:引言。
Dermatology. 2010;221 Suppl 1:1-5. doi: 10.1159/000316169. Epub 2010 Aug 9.